NIH #R01FD005106
Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [IND 121109 acknowledged 8/27/14]
- Amount
- $400K–$500K
- Period
- 2017-09-01 → 2023-08-31
- PIs
- 1
Awarded at ALBERT EINSTEIN COLLEGE OF MEDICINE